BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29807259)

  • 1. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
    Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
    Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
    Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
    Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene.
    Oksanen M; Hyötyläinen I; Voutilainen J; Puttonen KA; Hämäläinen RH; Graff C; Lehtonen Š; Koistinaho J
    Stem Cell Res; 2018 Aug; 31():181-185. PubMed ID: 30099334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 May; 37():101438. PubMed ID: 31004935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
    Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of two iPSC lines (ICGi008-A and ICGi008-B) from skin fibroblasts of a patient with early-onset Alzheimer's disease caused by London familial APP mutation (V717I).
    Grigor'eva EV; Malankhanova TB; Ustyantseva EI; Minina JM; Redina OE; Morozov VV; Shevela AI; Zakian SM; Medvedev SP
    Stem Cell Res; 2019 Apr; 36():101415. PubMed ID: 30851551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cell line (XWHNi002-A) from a female with APP gene mutation.
    Sun W; Wang P; Gong J; Chen Y; Yang Y; Luan H; Li S; Li R; Wei C
    Stem Cell Res; 2023 Sep; 71():103149. PubMed ID: 37356183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
    Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
    Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased plasma β-amyloid in the Alzheimer's disease APP A673T variant carriers.
    Martiskainen H; Herukka SK; Stančáková A; Paananen J; Soininen H; Kuusisto J; Laakso M; Hiltunen M
    Ann Neurol; 2017 Jul; 82(1):128-132. PubMed ID: 28556232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblast-derived integration-free iPSC line AD-TREM2-3 from a 74 year-old Alzheimer's disease patient expressing the TREM2 p.R47H variant.
    Martins S; Yigit H; Bohndorf M; Graffmann N; Fiszl AR; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2018 Jul; 30():141-144. PubMed ID: 29902745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
    Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease.
    Bamne MN; Demirci FY; Berman S; Snitz BE; Rosenthal SL; Wang X; Lopez OL; Kamboh MI
    Neurobiol Aging; 2014 Jul; 35(7):1779.e15-6. PubMed ID: 24529499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
    Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals.
    Liu YW; He YH; Zhang YX; Cai WW; Yang LQ; Xu LY; Kong QP
    Neurobiol Aging; 2014 Apr; 35(4):935.e11-2. PubMed ID: 24126161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.